Assessment of frequencies of lifestyle factors and polymorphisms of drug-metabolizing enzymes (NAT2, CYP2E1) in human hepatocellular carcinoma (HCC) patients in a department of surgical medicine--a pilot investigation.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples